{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T10:20:21Z","timestamp":1776334821256,"version":"3.51.2"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.intimp.2019.04.045","type":"journal-article","created":{"date-parts":[[2019,5,27]],"date-time":"2019-05-27T03:23:06Z","timestamp":1558927386000},"page":"429-436","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Aspernolide F, as a new cardioprotective butyrolactone against doxorubicin-induced cardiotoxicity"],"prefix":"10.1016","volume":"72","author":[{"given":"Dina S.","family":"El-Agamy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabrin R.M.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nishat","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saad","family":"Khoshhal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hany M.","family":"Abo-Haded","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed A.","family":"Elkablawy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naif","family":"Aljuhani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gamal A.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2019.04.045_bb0005","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1159\/000480471","article-title":"Oxymatrine ameliorates doxorubicin-induced cardiotoxicity in rats","volume":"43","author":"Zhang","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.intimp.2019.04.045_bb0010","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s00280-017-3413-7","article-title":"Allicin ameliorates doxorubicin-induced cardiotoxicity in rats via suppression of oxidative stress, inflammation and apoptosis","volume":"80","author":"Abdel-Daim","year":"2017","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.intimp.2019.04.045_bb0015","first-page":"175","article-title":"Hesperidin alleviates doxorubicin-induced cardiotoxicity in rats","volume":"21","author":"Abdel-Raheem","year":"2009","journal-title":"J. Egypt. Natl. Canc. Inst."},{"key":"10.1016\/j.intimp.2019.04.045_bb0020","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1177\/1535370216643418","article-title":"Cardioprotective effects of sitagliptin against doxorubicin-induced cardiotoxicity in rats","volume":"241","author":"El-Agamy","year":"2016","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"10.1016\/j.intimp.2019.04.045_bb0025","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40360-017-0184-z","article-title":"Enoxaparin attenuates doxorubicin induced cardiotoxicity in rats via interfering with oxidative stress, inflammation and apoptosis","volume":"19","author":"Shaker","year":"2018","journal-title":"BMC Pharmacol. Toxicol."},{"key":"10.1016\/j.intimp.2019.04.045_bb0030","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.2174\/1389557518666180305163151","article-title":"Potential anti-malarial agents from endophytic fungi: a review","volume":"18","author":"Ibrahim","year":"2018","journal-title":"Mini-Rev. Med. Chem."},{"key":"10.1016\/j.intimp.2019.04.045_bb0035","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.phytol.2015.09.006","article-title":"Aspernolides F and G, new butyrolactones from the endophytic fungus Aspergillus terreus","volume":"14","author":"Ibrahim","year":"2015","journal-title":"Phytochem. Lett."},{"key":"10.1016\/j.intimp.2019.04.045_bb0040","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S1286-4579(03)00073-X","article-title":"Endophytes as sources of bioactive products","volume":"5","author":"Strobel","year":"2003","journal-title":"Microbes Infect."},{"key":"10.1016\/j.intimp.2019.04.045_bb0045","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1080\/14786419.2015.1072711","article-title":"Terrenolide S, a new anti-leishmanial butenolide from the endophytic fungus Aspergillus terreus","volume":"30","author":"Elkhayat","year":"2016","journal-title":"Nat. Prod. Res."},{"key":"10.1016\/j.intimp.2019.04.045_bb0050","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1515\/znc-2016-0138","article-title":"Aspernolides L and M, new butyrolactones from the endophytic fungus Aspergillus versicolor","volume":"72","author":"Ibrahim","year":"2017","journal-title":"Z. Naturforsch. C"},{"key":"10.1016\/j.intimp.2019.04.045_bb0055","first-page":"791","article-title":"\u03b3-Butyrolactones from Aspergillus species: structures, biosynthesis, and biological activities","volume":"12","author":"Ibrahim","year":"2017","journal-title":"Nat. Prod. Commun."},{"key":"10.1016\/j.intimp.2019.04.045_bb0060","doi-asserted-by":"crossref","first-page":"178","DOI":"10.4103\/0253-7613.93844","article-title":"Cardioprotective effect of methanolic extract of Ixora coccinea Linn. leaves on doxorubicin-induced cardiac toxicity in rats","volume":"44","author":"Momin","year":"2012","journal-title":"Indian J. Pharmacol."},{"key":"10.1016\/j.intimp.2019.04.045_bb0065","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1177\/0960327115627685","article-title":"Effect of metformin and sitagliptin on doxorubicin-induced cardiotoxicity in adult male albino rats","volume":"35","author":"Sheta","year":"2016","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.intimp.2019.04.045_bb0070","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12906-016-1037-9","article-title":"Protective effect of Sheng-Mai Yin, a traditional Chinese preparation, against doxorubicin-induced cardiac toxicity in rats","volume":"16","author":"Ma","year":"2016","journal-title":"BMC Complement. Altern. Med."},{"key":"10.1016\/j.intimp.2019.04.045_bb0075","doi-asserted-by":"crossref","first-page":"637","DOI":"10.3109\/13880209.2015.1070879","article-title":"Ameliorative effect of naringin against doxorubicin-induced acute cardiac toxicity in rats","volume":"54","author":"Kwatra","year":"2016","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.intimp.2019.04.045_bb0080","first-page":"6139","article-title":"Octreotide protects doxorubicin-induced cardiac toxicity via regulating oxidative stress","volume":"22","author":"Dai","year":"2018","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.intimp.2019.04.045_bb0085","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1007\/s00210-017-1414-z","article-title":"Liraglutide ameliorates cardiotoxicity induced by doxorubicin in rats through the Akt\/GSK-3\u03b2 signaling pathway","volume":"390","author":"Abbas","year":"2017","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.intimp.2019.04.045_bb0090","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2147\/CMAR.S186696","article-title":"Pristimerin protects against doxorubicin-induced cardiotoxicity and fibrosis through modulation of Nrf2 and MAPK\/NF-kB signaling pathways","volume":"11","author":"El-Agamy","year":"2019","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.intimp.2019.04.045_bb0095","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s11101-012-9251-7","article-title":"Phytochemicals as a potential source for TNF-\u03b1 inhibitors","volume":"12","author":"Iqbal","year":"2013","journal-title":"Phytochem. Rev."},{"key":"10.1016\/j.intimp.2019.04.045_bb0100","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3390\/md16060202","article-title":"Butyrolactone-I from coral-derived fungus Aspergillus terreus attenuates neuro-inflammatory response via suppression of NF-\u03baB pathway in BV-2 cells","volume":"16","author":"Zhang","year":"2018","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.intimp.2019.04.045_bb0105","doi-asserted-by":"crossref","first-page":"13040","DOI":"10.1039\/C8RA01840E","article-title":"Anti-inflammatory butenolide derivatives from the coral-derived fungus Aspergillus terreus and structure revisions of aspernolides D and G, butyrolactone VI and 4\u2032,8\u2033-diacetoxy butyrolactone VI","volume":"8","author":"Liu","year":"2018","journal-title":"RSC Adv."},{"key":"10.1016\/j.intimp.2019.04.045_bb0110","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.fitote.2016.06.014","article-title":"Butenolide derivatives from the plant endophytic fungus Aspergillus terreus","volume":"113","author":"Guo","year":"2016","journal-title":"Fitoterapia"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757691930222X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757691930222X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:17:52Z","timestamp":1761585472000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156757691930222X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":22,"alternative-id":["S156757691930222X"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2019.04.045","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aspernolide F, as a new cardioprotective butyrolactone against doxorubicin-induced cardiotoxicity","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2019.04.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}